|
|
|
|
| LEADER |
03489cam a22004697i 4500 |
| 001 |
MUB03000004889 |
| 003 |
CZ BrMU |
| 005 |
20230530070320.0 |
| 008 |
180803t20152015xxu|||||o|||||||||||eng d |
| STA |
|
|
|a EIZ
|b 333
|c EBSCO trvale nakupy
|d 2018-07-31
|
| 020 |
|
|
|a 978-1-4822-2135-0
|q (eBook - PDF)
|
| 035 |
|
|
|a (OCoLC)ocn903644072
|
| 035 |
|
|
|a (OCoLC)903644072
|z (OCoLC)908092012
|
| 040 |
|
|
|a N$T
|b cze
|e rda
|c N$T
|d N$T
|d IDEBK
|d UIU
|d E7B
|d OCLCF
|d YDXCP
|d CRCPR
|d EBLCP
|d OCLCQ
|d NRC
|d OCLCQ
|d UAB
|d OCLCQ
|d ERL
|d UUM
|d BOD034
|
| 072 |
|
7 |
|a 615
|x Farmacie. Farmakologie
|2 Konspekt
|9 14
|
| 080 |
|
|
|a 615.033/.034
|2 MRF
|
| 100 |
1 |
|
|a Boroujerdi, Mehdi
|4 aut
|
| 245 |
1 |
0 |
|a Pharmacokinetics and toxicokinetics /
|c Mehdi Boroujerdi
|
| 264 |
|
1 |
|a Boca Raton, FL :
|b CRC Press,
|c [2015]
|
| 264 |
|
4 |
|c ©2015
|
| 300 |
|
|
|a 1 online zdroj (xix, 513 stran) :
|b ilustrace
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a počítač
|b c
|2 rdamedia
|
| 338 |
|
|
|a online zdroj
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Chapter 1. The influence of routes of administration on ADME -- chapter 2. Mechanisms of absorption and permeation of xenobiotics -- chapter 3. In Vivo distribution of xenobiotics -- chapter 4. Elimination rate, clearance, and the theoretical models -- chapter 5. Renal excretion of xenobiotics and estimation of related PK/TK parameters and constants -- chapter 6. Biotransformation of xenobiotics -- chapter 7. Kinetics of In Vitro metabolism : assimilation of intrinsic clearance in hepatic clearance -- chapter 8. Pharmaceutical, biopharmaceutical, and physiological factors influencing oral absorption : mechanistic absorption models -- chapter 9. Mathematical modeling in pharmacokinetics and toxicokinetics -- chapter 10. PK/TK analysis of instantaneous exposure to xenobiotics (single bolus injection) -- chapter 11. PK/TK analysis of continuous zero-order exposure to xenobiotics (intravenous infusion) -- chapter 12. PK/TK analysis of xenobiotics absorbed via an extravascular route of administration (oral administration) -- chapter 13. PK/TK of xenobiotics absorbed through the skin (transdermal absorption) -- chapter 14. PK/TK analysis of multiple dosing -- chapter 15. Bioavailability, bioequivalence, and biosimilar evaluations -- chapter 16. Preclinical PK/TK and clinical trials -- chapter 17. Population pharmacokinetics/toxicokinetics -- chapter 18. Quantitative extrapolation interspecies scaling/low dose extrapolation
|
| 533 |
|
|
|a Elektronická reprodukce.
|n Přístup pouze pro oprávněné uživatele
|
| 650 |
0 |
7 |
|a farmakokinetika
|2 czmesh
|
| 650 |
0 |
2 |
|a Pharmacokinetics
|
| 655 |
|
7 |
|a e-knihy online
|2 CZ-BrMU
|
| 655 |
|
9 |
|a e-books online
|2 eCZ-BrMU
|
| 776 |
0 |
8 |
|i Tištěná verze:
|t Pharmacokinetics and toxicokinetics.
|z 978-1-4822-2134- 3
|
| 856 |
4 |
1 |
|z Elektronická verze přístupná pouze pro studenty a pracovníky MU
|u https://ezproxy.muni.cz/login?url=https://search.ebscohost.com/login.aspx?authtype=ip&custid=s8431878&lang=cs&profile=eds&direct=true&db=nlebk&AN=957544
|
| CAT |
|
|
|c 20180803
|l MUB03
|h 1520
|
| CAT |
|
|
|c 20190222
|l MUB03
|h 1623
|
| CAT |
|
|
|c 20190222
|l MUB03
|h 1659
|
| CAT |
|
|
|c 20210421
|l MUB03
|h 2124
|
| CAT |
|
|
|c 20210421
|l MUB03
|h 2208
|
| CAT |
|
|
|a VARTECKA
|b 02
|c 20230530
|l MUB03
|h 0703
|
| 995 |
|
|
|a eBook
|
| 994 |
- |
1 |
|l MUB03
|l MUB03
|m EBOOK
|1 KUK
|a Knihovna univ. kampusu
|2 VV
|b KUK - volný výběr
|5 3284L00167
|8 20180801
|f 83
|f Dálkově přístupná
|s kup
|
| AVA |
|
|
|a MED50
|b KUK
|c KUK - volný výběr
|e available
|t K dispozici
|f 1
|g 0
|h N
|i 0
|j VV
|
